This was accompanied by inhibition of the NF-κB signaling pathway and suppression of nuclear p65 expression, suggesting adiponectin’s critical role in modulating vascular inflammation and slowing atherosclerosis progression [145]. Here, ADIPOQ is linked to atherosclerosis.